O
About
Myriad Genetics is a leading genetic testing company that integrates artificial intelligence and genomic data to power a broad portfolio of diagnostic and predictive tests. Their offerings span hereditary cancer risk assessment (MyRisk®), cancer treatment guidance (MyChoice® CDx, EndoPredict®, Prolaris®), prenatal screening (Prequel®, Foresight®, SneakPeek®, FirstGene®), and pharmacogenomic mental health testing (GeneSight®). By analyzing a patient's DNA, Myriad's AI-enhanced platforms help clinicians identify cancer susceptibility gene variants, select optimal cancer therapies, assess fetal chromosomal conditions, and predict how patients will metabolize psychiatric medications. The platform supports seamless EMR integrations, a provider portal, and ordering workflows that fit into existing clinical environments. Myriad's tests serve a wide range of specialties including oncology, urology, OB/GYN, internal medicine, and mental health. Biopharma and health system partners can also leverage Myriad's data and technology for research and precision medicine initiatives. With a proven track record backed by extensive scientific publications, Myriad Genetics bridges cutting-edge genomics with practical, actionable clinical insights for both patients and healthcare providers.
Key Features
- Hereditary Cancer Risk Assessment: MyRisk® analyzes key cancer susceptibility genes to identify patients at elevated risk for hereditary cancers, enabling proactive screening and prevention strategies.
- Cancer Treatment Guidance: Tests like MyChoice® CDx, EndoPredict®, and Prolaris® leverage tumor genomics to help oncologists select the most effective treatment protocols for breast, ovarian, prostate, and other cancers.
- Prenatal Genetic Screening: Prequel®, Foresight®, SneakPeek®, and FirstGene® screen for chromosomal conditions, genetic diseases, and fetal sex, giving expectant parents and OB/GYN providers critical early information.
- Pharmacogenomic Mental Health Testing: GeneSight® analyzes how a patient's genes affect their metabolism and response to psychiatric medications, guiding more personalized treatment for depression, anxiety, and ADHD.
- EMR Integration & Provider Portal: Seamless integration with electronic medical record systems and a dedicated provider portal streamline test ordering, results delivery, and clinical workflows.
Use Cases
- A patient with a family history of breast cancer uses MyRisk® to assess their hereditary cancer susceptibility and guide preventive care decisions.
- An oncologist orders MyChoice® CDx for an ovarian cancer patient to determine eligibility for PARP inhibitor therapy based on tumor genomics.
- An expectant mother undergoes Prequel® prenatal screening to evaluate the risk of chromosomal conditions such as Down syndrome in her pregnancy.
- A psychiatrist uses GeneSight® to identify which antidepressants are most likely to be effective and well-tolerated based on a patient's pharmacogenomic profile.
- A health system integrates Myriad's EMR-connected tests to streamline hereditary cancer screening workflows across their network of oncology clinics.
Pros
- Comprehensive Test Portfolio: Covers a wide spectrum of genetic testing needs—from cancer risk and oncology to prenatal and mental health—under one platform, reducing the need for multiple vendors.
- Clinically Validated & Evidence-Based: Backed by extensive peer-reviewed scientific publications and regulatory clearances (e.g., CDx-designated tests), ensuring high clinical credibility and confidence.
- Seamless Clinical Integration: EMR integrations and a dedicated provider portal make it straightforward to embed Myriad's tests into existing clinical workflows with minimal friction.
Cons
- Cost & Insurance Variability: Genetic tests can be expensive, and coverage varies widely by insurance plan, potentially creating financial barriers for some patients despite available assistance programs.
- Specialized Use Case: Designed exclusively for healthcare and clinical settings; not a general-purpose AI tool, limiting its applicability outside the medical domain.
Frequently Asked Questions
What types of genetic tests does Myriad Genetics offer?
Myriad offers tests for hereditary cancer risk (MyRisk®), cancer treatment selection (MyChoice® CDx, EndoPredict®, Prolaris®), prenatal screening (Prequel®, Foresight®, SneakPeek®), and mental health pharmacogenomics (GeneSight®).
How does Myriad Genetics use AI in its testing?
Myriad integrates AI and machine learning into its genomic analysis pipelines to interpret complex genetic data, identify pathogenic variants, predict disease risk, and match patients to optimal treatments based on their unique genetic profiles.
Can healthcare providers integrate Myriad tests into their existing EMR systems?
Yes. Myriad offers EMR integrations and a provider portal that allow clinicians to order tests, receive results, and manage patient data within their existing clinical workflows.
Is financial assistance available for patients who cannot afford genetic testing?
Yes. Myriad has financial assistance programs to help eligible patients access testing regardless of insurance status, and they provide transparent cost information on their website.
Who is Myriad Genetics designed for?
Myriad serves patients seeking genetic insights, healthcare providers across oncology, OB/GYN, mental health, and primary care specialties, as well as health systems and biopharma companies engaged in precision medicine research.
